LLMpediaThe first transparent, open encyclopedia generated by LLMs

Nature Biomedical Engineering

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 82 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted82
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Nature Biomedical Engineering
TitleNature Biomedical Engineering
DisciplineBiomedical engineering
AbbreviationNat. Biomed. Eng.
PublisherNature Publishing Group
History2017–present
FrequencyMonthly

Nature Biomedical Engineering Nature Biomedical Engineering is a monthly peer-reviewed scientific journal covering biomedical engineering research, translational medicine, and bioengineering innovations. The journal publishes original research, reviews, perspectives, and commentaries that intersect with clinical practice, biotechnology, materials science, and regulatory affairs. Articles often involve collaborations among investigators at academic institutions, industrial laboratories, hospitals, and funding agencies.

History

The journal was launched in 2017 by Nature Publishing Group as part of an expansion of the Nature portfolio into applied biomedical sciences, following the creation of titles such as Nature Communications, Nature Medicine, and Nature Biotechnology. Its foundation drew on editorial leadership experienced with journals like Nature Materials, Nature Nanotechnology, and Nature Photonics, and it was announced during meetings attended by representatives from organizations including the European Research Council, the National Institutes of Health, and the Wellcome Trust. Early editorial board members included researchers with affiliations to institutions such as Massachusetts Institute of Technology, Stanford University, Harvard University, University of Cambridge, and Johns Hopkins University. The launch reflected convergence trends also seen at conferences like the AAAS Annual Meeting and the IEEE Engineering in Medicine and Biology Society symposia.

Scope and aims

The journal aims to publish interdisciplinary work spanning areas such as biomedical devices, tissue engineering, synthetic biology, medical imaging, computational biology, drug delivery, and biomaterials. It solicits submissions that bridge laboratories at places like Broad Institute, Salk Institute, Max Planck Society, Cold Spring Harbor Laboratory, and hospitals such as Mayo Clinic, Cleveland Clinic, and Karolinska University Hospital. The stated goals align with priorities articulated by funding bodies including the European Commission, the National Science Foundation, and philanthropic actors such as the Bill & Melinda Gates Foundation. Topics commonly addressed relate to translational pathways involving regulatory agencies like the Food and Drug Administration, reimbursement environments influenced by bodies like the Centers for Medicare & Medicaid Services, and commercialization ecosystems intersecting with firms such as Pfizer, Roche, Siemens Healthineers, and Medtronic.

Editorial structure and publishing model

The journal operates under an editorial office based in the United Kingdom and follows peer-review procedures employed across the Nature Research journals. Its editorial board has included academics and clinicians from universities such as University of Oxford, Imperial College London, University of California, Berkeley, University of California, San Francisco, and UCSF Medical Center as well as industry advisors from companies like Johnson & Johnson and GlaxoSmithKline. The publication model combines subscription access with options for open-access publishing through article-processing charges, reflecting publishing frameworks used by titles including Nature Communications and Scientific Reports. Editorial policies reference guidelines from organizations such as the Committee on Publication Ethics and standards adopted by consortia like COPE and CrossRef. The journal issues corrections, retractions, and expressions of concern consistent with practices at outlets like The Lancet and Science (journal).

Abstracting and indexing

Articles are indexed in major bibliographic databases and indexing services used by researchers and librarians working with resources such as PubMed, MEDLINE, Web of Science, Scopus, and Embase. Metadata integration supports discovery via platforms maintained by organizations including ORCID, CrossRef, and library services at institutions like National Library of Medicine and the British Library. Citation metrics reported by aggregators such as Clarivate Analytics and Elsevier feed into bibliometric analyses deployed by research offices at universities including Yale University, Princeton University, and University of Tokyo.

Reception and impact

Since its inception, the journal has been referenced in discussions involving award committees such as those for the Lasker Award, the Breakthrough Prize, and national research assessment exercises like the Research Excellence Framework. High-profile papers published in the journal have been covered by science sections of media outlets including The New York Times, The Guardian, Nature news, and BBC News. Influence on the fields of biomedical engineering and translational medicine can be seen in citations across disciplines and in adoption of techniques by groups at laboratories like Argonne National Laboratory, Lawrence Berkeley National Laboratory, and clinical trial centers affiliated with National Cancer Institute and European Organisation for Research and Treatment of Cancer.

Notable publications and controversies

Notable publications have included reports on engineered biomaterials, microfluidic diagnostics, CRISPR-based therapeutic strategies, organ-on-chip platforms, and neural interface devices with authors from institutions such as California Institute of Technology, ETH Zurich, University of Pennsylvania, Columbia University, and University of Michigan. Controversies associated with the journal have mirrored broader debates in biomedical publishing, including disputes over data reproducibility raised by groups like the Reproducibility Project and methodological critiques cited by investigators at Karolinska Institutet and Cold Spring Harbor Laboratory. Editorial decisions and retractions have prompted commentary from stakeholders including the Retraction Watch community, policy analysts at Wellcome Trust, and ethicists at centers such as Hastings Center.

Category:Academic journals